Strahm, Emmanuel; Baume, Norbert; Mangin, Patrice; Saugy, Martial; Ayotte, Christiane ORCID: https://orcid.org/0000-0002-6352-2071 et Saudan, Christophe (2009). Profiling of 19-norandrosterone sulfate and glucuronide in human urine: Implications in athlete's drug testing Steroids , vol. 74 , nº 3. pp. 359-364. DOI: 10.1016/j.steroids.2008.11.005.
Ce document n'est pas hébergé sur EspaceINRS.Résumé
19-Norandrosterone (19-NA) as its glucuronide derivative is the target metabolite in anti-doping testing to reveal an abuse of nandrolone or nandrolone prohormone. To provide further evidence of a doping with these steroids, the sulfoconjugate form of 19-norandrosterone in human urine might be monitored as well. In the present study, the profiling of sulfate and glucuronide derivatives of 19-norandrosterone together with 19-noretiocholanolone (19-NE) were assessed in the spot urines of 8 male subjects, collected after administration of 19-nor-4-androstenedione (100 mg). An LC/MS/MS assay was employed for the direct quantification of sulfoconjugates, whereas a standard GC/MS method was applied for the assessment of glucuroconjugates in urine specimens. Although the 19-NA glucuronide derivative was always the most prominent at the excretion peak, inter-individual variability of the excretion patterns was observed for both conjugate forms of 19-NA and 19-NE. The ratio between the glucuro- and sulfoconjugate derivatives of 19-NA and 19-NE could not discriminate the endogenous versus the exogenous origin of the parent compound. However, after ingestion of 100 mg 19-nor-4-androstenedione, it was observed in the urine specimens that the sulfate conjugates of 19-NA was detectable over a longer period of time with respect to the other metabolites. These findings indicate that more interest shall be given to this type of conjugation to deter a potential doping with norsteroids.
Type de document: | Article |
---|---|
Mots-clés libres: | Nandrolone; Sulfoconjugates; Urinary marker; Endogenous; Isotope ratio mass spectrometry (IRMS); Doping control |
Centre: | Centre INRS-Institut Armand Frappier |
Date de dépôt: | 29 juin 2024 21:52 |
Dernière modification: | 29 juin 2024 21:52 |
URI: | https://espace.inrs.ca/id/eprint/15196 |
Gestion Actions (Identification requise)
Modifier la notice |